Finance

Lists
Why is ATHE down 6.44%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
US$1.96
-6.44%
(-0.13) 1D
US$1.96
0.00% (0.00)
After hours
Closed: ኖቬም 13, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
US$2.04
High
US$2.14
Low
US$1.70
Mkt. cap
36.60 ሚ
Avg. vol.
165.56 ሺ
Volume
109.69 ሺ
52-wk high
US$5.89
52-wk low
US$1.70
EPS
-US$0.91
Beta
0.39
Shares outstanding
19.10 ሚ
No. of employees
11
Open
US$2.04
High
US$2.14
Low
US$1.70
Mkt. cap
36.60 ሚ
Avg. vol.
165.56 ሺ
Volume
109.69 ሺ
52-wk high
US$5.89
52-wk low
US$1.70
EPS
-US$0.91
Beta
0.39
Shares outstanding
19.10 ሚ
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
Headquartersመልበርን, Victoria, አውስትራልያ
SectorHealth Care
IndustryBiotechnology
Websitealteritytx.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current US$1.96
US$16.00 (+716.33%)
Average
US$13.67 (+597.45%)
Lowest
US$10.00 (+410.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$10.00
+410.2%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
US$15.00
+665.3%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
US$16.00
+716.3%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
US$10.00
+410.2%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
US$10.00
+410.2%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
US$12.00
+512.2%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
1.40 ሚ
1.40 ሚ
403.29 ሺ
403.29 ሺ
Cost of goods sold
49.43 ሺ
49.43 ሺ
81.96 ሺ
81.96 ሺ
Cost of revenue
49.43 ሺ
49.43 ሺ
81.96 ሺ
81.96 ሺ
Research and development expenses
3.92 ሚ
3.92 ሚ
4.89 ሚ
4.89 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.56 ሚ
2.56 ሚ
2.71 ሚ
2.71 ሚ
Operating expense
6.57 ሚ
6.57 ሚ
7.65 ሚ
7.65 ሚ
Total operating expenses
6.62 ሚ
6.62 ሚ
7.73 ሚ
7.73 ሚ
Operating income
-5.22 ሚ
-5.22 ሚ
-7.32 ሚ
-7.32 ሚ
Other non operating income
-
-
-
-
EBT including unusual items
-4.78 ሚ
-4.78 ሚ
-6.87 ሚ
-6.87 ሚ
EBT excluding unusual items
-4.78 ሚ
-4.78 ሚ
-6.87 ሚ
-6.87 ሚ
Income tax expense
30.78 ሺ
30.78 ሺ
25.97 ሺ
25.97 ሺ
Effective tax rate
-0.64%
-0.64%
-0.38%
-0.38%
Other operating expenses
95.67 ሺ
95.67 ሺ
46.26 ሺ
46.26 ሺ
Net income
-4.81 ሚ
-4.81 ሚ
-6.89 ሚ
-6.89 ሚ
Net profit margin
-343.00%
-343.00%
-1,709.06%
-1,709.06%
Earnings per share
-
-
-
-
Interest and investment income
454.88 ሺ
454.88 ሺ
403.45 ሺ
403.45 ሺ
Interest expense
-
-
-
-
Net interest expenses
454.88 ሺ
454.88 ሺ
403.45 ሺ
403.45 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.22 ሚ
-5.22 ሚ
-7.32 ሚ
-7.32 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች